BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 08, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Bromday bromfenac regulatory update

FDA said it would not approve an sNDA from Ista for Bromday bromfenac in a 2.4 mL fill size to treat ocular inflammation and pain following cataract surgery. The agency said Ista has not...

Read the full 149 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >